Advertisement
Advertisement

CYBN

CYBN logo

Cybin Inc

9.51
USD
+0.04
+0.42%
Dec 18, 14:54 UTC -5
Open

Cybin Inc Profile

About

Cybin Inc. is a biotechnology company. It is focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders. Cybin Inc. is based in Toronto, Canada.

Info & Links

CEO

Douglas Drysdale

Headquarters

100 KING STREET WEST, SUITE 5600
TORONTO, A6 M5X 1C9, CANADA

Industry

Pharmaceuticals Major

Sector

Health Technology

Website

www.cybin.com

Auditor

Laurence W. Zeifman, CPA, CA

Share holders

--

Employees

50

Cybin Inc Statistics

Valuation Measures

Market Capitalization2

190.10M

Enterprise Value

77.09M

Enterprise Value/EBITDA(ttm)

-0.81

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.05

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-52.17%

Return on Invested Capital(ttm)

-60.11%

Return on Assets(ttm)

-50.52%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

--

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-95.75M

Net Income Available to Common(ttm)

-90.98M

Diluted EPS(ttm)

-6.66

Share Statistics

Beta (5Y Monthly)

0.39

52-Week Change

-44.05%

S&P 500 52-Week Change

26.73%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

16.99M

% Held by Insiders

15.00%

% Held by Institutions

17.94%

Balance Sheet

Total Cash(mrq)

113.12M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

97.50K

Total Debt/Equity(mrq)

0.05%

Current Ratio(mrq)

24.24%

Quick Ratio(mrq)

24.24%

Book Value Per Share(mrq)

9.35

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.94

Free Cash Flow(ytd)

-39.32M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement